Literature DB >> 28960421

Circulating Levels of Brain-Derived Neurotrophic Factor and History of Suicide Attempts in Women.

Anastacia Y Kudinova1, Terrence Deak1, Molly M Deak1, Brandon E Gibb1.   

Abstract

A growing body of research examining biological factors associated with suicidal behaviors highlights the role of brain-derived neurotropic factor (BDNF), involved in neurogenesis and synaptic plasticity. There is evidence suggesting that suicide attempters have lower BDNF levels than those with no history of suicide attempts. The key question addressed in the current investigation is whether differences in circulating BDNF levels persist beyond the current suicidal episode and would be observed in those with a past history of suicide attempts (SA). Plasma levels of BDNF were assessed in 73 women from the community. We found that women with a history of SA exhibited lower levels of BDNF than women with no SA history and this difference was maintained after statistically controlling for the influence of other potential psychiatric or demographic factors. These findings support and extend existing research by suggesting that circulating BDNF levels are decreased among individuals with a history of SA compared to individuals with no history of SA. This relation appeared to be specific to women's history of SA and was not explained by other potential psychiatric or demographic factors, which further highlights the role of BDNF as a promising biomarker for suicidal behavior.
© 2017 The American Association of Suicidology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28960421      PMCID: PMC5874157          DOI: 10.1111/sltb.12403

Source DB:  PubMed          Journal:  Suicide Life Threat Behav        ISSN: 0363-0234


  40 in total

1.  Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides.

Authors:  Susana G Torres-Platas; Christa Hercher; Maria Antonietta Davoli; Gilles Maussion; Benoit Labonté; Gustavo Turecki; Naguib Mechawar
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 2.  Systematic review of risk factors for suicide and suicide attempt among psychiatric patients in Latin America and Caribbean.

Authors:  Germán L Teti; Federico Rebok; Sasha M Rojas; Leandro Grendas; Federico M Daray
Journal:  Rev Panam Salud Publica       Date:  2014-08

3.  Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor.

Authors:  T Nakahashi; H Fujimura; C A Altar; J Li; J Kambayashi; N N Tandon; B Sun
Journal:  FEBS Lett       Date:  2000-03-24       Impact factor: 4.124

4.  Brain-derived neurotrophic factor in platelets and airflow limitation in asthma.

Authors:  Marek Lommatzsch; Katharina Schloetcke; Jens Klotz; Katharina Schuhbaeck; Doerte Zingler; Christiana Zingler; Olaf Schulte-Herbrüggen; Hartmut Gill; Peter Schuff-Werner; Johann Christian Virchow
Journal:  Am J Respir Crit Care Med       Date:  2004-10-29       Impact factor: 21.405

5.  Hopelessness mediates the relation between insomnia and suicidal ideation.

Authors:  Julie A Woosley; Kenneth L Lichstein; Daniel J Taylor; Brant W Riedel; Andrew J Bush
Journal:  J Clin Sleep Med       Date:  2014-11-15       Impact factor: 4.062

6.  Essential role of brain-derived neurotrophic factor in adult hippocampal function.

Authors:  Lisa M Monteggia; Michel Barrot; Craig M Powell; Olivier Berton; Victor Galanis; Terry Gemelli; Sven Meuth; Andreas Nagy; Robert W Greene; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury.

Authors:  M J Donovan; R C Miranda; R Kraemer; T A McCaffrey; L Tessarollo; D Mahadeo; S Sharif; D R Kaplan; P Tsoulfas; L Parada
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 8.  Brain-Derived Neurotrophic Factor and Suicide in Schizophrenia: Critical Role of Neuroprotective Mechanisms as an Emerging Hypothesis.

Authors:  Amresh Shrivastava; Avinash De Sousa; G Prasad Rao
Journal:  Indian J Psychol Med       Date:  2016 Nov-Dec

9.  Exploring the Association between Serum BDNF and Attempted Suicide.

Authors:  Rebecca B Eisen; Stefan Perera; Monica Bawor; Brittany B Dennis; Wala El-Sheikh; Jane DeJesus; Sumathy Rangarajan; Judith Vair; Heather Sholer; Nicole Hutchinson; Elizabeth Iordan; Pam Mackie; Shofiqul Islam; Mahshid Dehghan; Jennifer Brasch; Rebecca Anglin; Luciano Minuzzi; Lehana Thabane; Zainab Samaan
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379

10.  The Vulnerability to Suicidal Behavior is Associated with Reduced Connectivity Strength.

Authors:  Stijn Bijttebier; Karen Caeyenberghs; Hans van den Ameele; Eric Achten; Dan Rujescu; Koen Titeca; Cornelis van Heeringen
Journal:  Front Hum Neurosci       Date:  2015-11-30       Impact factor: 3.169

View more
  3 in total

Review 1.  Suicide Biomarkers to Predict Risk, Classify Diagnostic Subtypes, and Identify Novel Therapeutic Targets: 5 Years of Promising Research.

Authors:  Jenessa N Johnston; Darcy Campbell; Hector J Caruncho; Ioline D Henter; Elizabeth D Ballard; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2022-03-17       Impact factor: 5.176

2.  Investigating Predictive Factors of Suicidal Re-attempts in Adolescents and Young Adults After a First Suicide Attempt, a Prospective Cohort Study. Study Protocol of the SURAYA Project.

Authors:  Erika Abrial; Benoît Chalancon; Edouard Leaune; Jérôme Brunelin; Martine Wallon; Frédéric Moll; Nadine Barakat; Benoit Hoestlandt; Anthony Fourier; Louis Simon; Charline Magnin; Marianne Hermand; Emmanuel Poulet
Journal:  Front Psychiatry       Date:  2022-06-29       Impact factor: 5.435

3.  Suicide Reduction in Schizophrenia via Exercise (SUnRISE): study protocol for a multi-site, single-blind, randomized clinical trial of aerobic exercise for suicide risk reduction in individuals with schizophrenia.

Authors:  Katie Beck-Felts; Marianne Goodman; Luz H Ospina; Melanie Wall; Joseph McEvoy; Lars F Jarskog; Jacob S Ballon; Matthew N Bartels; Richard Buchsbaum; Richard P Sloan; T Scott Stroup; David Kimhy
Journal:  Trials       Date:  2020-10-21       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.